CORC

浏览/检索结果: 共7条,第1-7条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors 期刊论文
BMC Medicine, 2022, 卷号: 20, 期号: 1
作者:  Zhang,Pei;  Du,Yang;  Bai,Hua;  Wang,Zhijie;  Duan,Jianchun
收藏  |  浏览/下载:123/0  |  提交时间:2022/11/21
Effects of Sensitized Sorafenib with a Paeoniflorin and Geniposide Mixture on Liver Cancer via the NF-kappa B-HIF-2 alpha-SerpinB3 Pathway 期刊论文
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 卷号: 2022
作者:  Li, Jun-Fei;  Zheng, Xiao-Rong;  Zhang, Hong-Yan;  Shen, Chang-Ming;  Shen, Guo-xin
收藏  |  浏览/下载:20/0  |  提交时间:2022/12/23
Neoadjuvant immunotherapy in non-small-cell lung cancer: a narrative review on mechanisms, efficacy and safety 期刊论文
JOURNAL OF THORACIC DISEASE, 2022
作者:  Shao, Lan;  Lou, Guangyuan
收藏  |  浏览/下载:18/0  |  提交时间:2022/12/22
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial 期刊论文
BMC MEDICINE, 2022, 卷号: 20
作者:  Song, Zhengbo;  Lou, Guangyuan;  Wang, Yina;  Yang, Zhiping;  Wang, Wenxian
收藏  |  浏览/下载:15/0  |  提交时间:2022/12/23
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Jing;  Lin, Zhongqiu;  Yin, Rutie
收藏  |  浏览/下载:104/0  |  提交时间:2022/03/28
Biomimetic manganese-eumelanin nanocomposites for combined hyperthermia-immunotherapy against prostate cancer 期刊论文
Journal of Nanobiotechnology, 2022, 卷号: 20, 期号: 1
作者:  Liu,Yu;  Shang,Wenting;  Liu,Heng;  Hui,Hui;  Wu,Jun
收藏  |  浏览/下载:44/0  |  提交时间:2022/02/16
Anlotinib enhances the antitumor immunity of radiotherapy by activating cGAS 期刊论文
CELL DEATH DISCOVERY, 2022, 卷号: 8, 期号: 1
作者:  Dong Han;  Jiajia Zhang;  Yawei Bao;  Lei Liu;  Ping Wang
收藏  |  浏览/下载:0/0  |  提交时间:2024/05/07


©版权所有 ©2017 CSpace - Powered by CSpace